Drugs / Highly purified menotrophin
Highly purified menotrophin
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT00884221 | Jul 2009 → Jul 2010 | infertility disorder | Ferring Pharmaceuticals | Completed | Met primary |
Evidence & citations 5 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Highly purified menotrophin | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00884221 ↗ |
| Known as | highly purified hMG | “Highly purified hMG is at least as effective as rFSH in GnRH antagonist cycles with compulsory single-blastocyst transfer.” PMID 22244781 ↗ Jan 2012 |
| Known as | highly purified menotropin | “highly purified menotropin (hphMG) and recombinant FSH (rFSH)” PMID 22244781 ↗ Jan 2012 |
| Known as | hphMG | “highly purified menotropin (hphMG) and recombinant FSH (rFSH)” PMID 22244781 ↗ Jan 2012 |
| Modality | Protein / enzyme biologic | “highly purified human menopausal gonadotropin (hphMG)” PMID 23394782 ↗ Feb 2013 |